Gossamer Bio Inc - ESG Rating & Company Profile powered by AI
This Disclosure score covers seventeen United Nations Sustainable Development Goals including: 'Zero Hunger', 'Industry, Innovation & Infrastructure' and 'Peace, Justice & Strong Institutions'. Detailed ESG assessment of Gossamer Bio Inc are reached by signing up for free. This analysis of Gossamer Bio Inc was assembled by All Street Sevva using cutting edge machine learning.
Gossamer Bio Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.9; made up of an environmental score of 4.0, social score of 1.6 and governance score of 3.2.
2.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1336 | SyneuRx International (Taiwan) Corp | 3.0 | Medium |
| 1336 | Sensorion SA | 3.0 | Medium |
| 1353 | Gossamer Bio Inc | 2.9 | Medium |
| 1353 | Caribou Biosciences Inc | 2.9 | Medium |
| 1353 | Checkmate Pharmaceuticals Inc | 2.9 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Gossamer Bio Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Gossamer Bio Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Gossamer Bio Inc report the average age of the workforce?
Sign up for free to unlockDoes Gossamer Bio Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Gossamer Bio Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Gossamer Bio Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Gossamer Bio Inc offer flexible work?
Sign up for free to unlockDoes Gossamer Bio Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Gossamer Bio Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Gossamer Bio Inc conduct supply chain audits?
Sign up for free to unlockDoes Gossamer Bio Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Gossamer Bio Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Gossamer Bio Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Gossamer Bio Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Gossamer Bio Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Gossamer Bio Inc disclose water use targets?
Sign up for free to unlockDoes Gossamer Bio Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Gossamer Bio Inc have a product recall in the last two years?
Sign up for free to unlockDoes Gossamer Bio Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Gossamer Bio Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Gossamer Bio Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Gossamer Bio Inc disclose parental leave metrics?
Sign up for free to unlockDoes Gossamer Bio Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Gossamer Bio Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Gossamer Bio Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Gossamer Bio Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Gossamer Bio Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Gossamer Bio Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Gossamer Bio Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Gossamer Bio Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Gossamer Bio Inc disclose its waste policy?
Sign up for free to unlockDoes Gossamer Bio Inc report according to TCFD requirements?
Sign up for free to unlockDoes Gossamer Bio Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Gossamer Bio Inc disclose energy use targets?
Sign up for free to unlockDoes Gossamer Bio Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Gossamer Bio Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Gossamer Bio Inc
These potential risks are based on the size, segment and geographies of the company.
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.